Toggle Offcanvas
...
 
Guselkumab Tenders

Guselkumab Tenders

View Guselkumab tenders, RFPs and contracts. Bid on readily available Guselkumab tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Guselkumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Guselkumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Guselkumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Guselkumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

15 Live Notices for Guselkumab Tenders

Showing 1 to 15

Delivery Of Program And Other Medications
country Poland
posting date31 Jan 2025
deadline10 Feb 2025
0000539/2024 Contr 2024 0000890653 +6.6L2M4W4 Framework Agreement With A Single Company, Per Lot, Establishing The Conditions For The Successive Supply Of Medicines Exclusive To Janssen-Cilag, S.A., Used In Health Centers Attached To The Almería Provincial Purchasing Center.
country Spain
posting date31 Jan 2025
deadline14 Feb 2025
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab
country Germany
posting date09 Dec 2024
deadline10 Nov 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Guselkumab (L04Ac16) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date06 Nov 2024
deadline31 Oct 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Guselkumab (L04Ac16) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date06 Nov 2024
deadline31 Oct 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab (Only In The Strength 100 Mg), (Obo), Atc L04Ac16 For The Period 01.12.2024 - 30.11.2026
country Germany
posting date16 Oct 2024
deadline05 Oct 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab (Only In The Strength 100 Mg), (Obo), Atc L04Ac16 For The Period 01.12.2024 - 30.11.2026
country Germany
posting date16 Oct 2024
deadline05 Oct 2026
Medicines Containing The Active Substance Guselkumab (Atc: L04Ac16)
country Germany
posting date22 Jun 2024
deadline31 May 2026
Ex-Ante Transparency Announcement Contract According To § 130C Sgb V Drug Tremfya (R) Active Ingredient: Guselkumab Atc Code: L04Ac16
country Germany
posting date23 Apr 2024
deadline18 Apr 2025

Share Share this page